Plerixafor is a bicyclam compound that acts as a CXCR4 chemokine receptor antagonist. It is primarily recognized for its ability to mobilize hematopoietic stem cells from the bone marrow into the peripheral bloodstream.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Plerixafor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N2-acetylaciclovir
pharmaceutical raw material
Ascomycin
pharmaceutical raw material
Petrolite E 2020
pharmaceutical raw material
Temocapril hydrochloride
pharmaceutical raw material
The international HS code for Plerixafor (CAS 110078-46-1) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane
YIQPUIGJQJDJOS-UHFFFAOYSA-N
C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3
Sourcing Plerixafor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.